Parenteral Solutions (SVP and LVP)
Grifols Partnership provides sterile injection solutions (small and large volume parenterals) for human and veterinary pharmaceuticals, including our portfolio and custom-developed products to meet your needs.
Lifecycle Management for Injectable Products
Why we are moving customers from concentrated formula to a ready to use solution?
Active product lifecycle management enhances competitiveness for injectable drug companies. The best practice is moving from vials (concentrated) to premixed solutions to avail of advantages which include:
- Reduces container handling, minimizing contamination and medical errors.
- Enhances patient safety by minimizing the risk of incorrect dosing.
- Increases physician safety by eliminating needle use and reducing contact with cytotoxic drugs.
- Reformulations improve efficacy or reduce injection frequency.
Choosing the right CDMO
Consider the CDMO's experience and knowledge when selecting the manufacturer for such projects. Choose a CDMO offering development and manufacturing from vial containers to premixed solutions. This approach fosters a long-term partnership with the CDMO, considering manufacturing capacity, regulatory compliance, investments, and launch schedules.
Continuing with the same CDMO saves time, costs and builds trust. Given the expected growth in the pharmaceutical contract manufacturing market, selecting the right CDMO can significantly impact your company's future success.
Facilitating tech transfer for parenteral products
Advancing Patient-Centric Parenteral Drug Strategies
Diluents for Reconstitution
Grifols offers our Water for Injection Drug Master File (DMF), because we know that diluent is as important as your API.